Cencora (COR): Viking Global added to its stake +1.01M shares
Viking Global added to its stake in Cencora, per its Q2 2025 13F.
- 2.08M
- Shares reported · +1.01M vs prior quarter
- 1.8%
- Disclosed portfolio weight
- $624M
- Reported value
- Holdings as of
- Jun 30, 2025
- Filed
- Aug 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
- Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
- Jun 24, 2025InsiderChair sold ~$4.27M of COR shares in the open market
- Jul 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
- Jul 22, 2025InsiderChair sold ~$4.27M of COR shares in the open market
- Jul 29, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [6…
What came next
- Aug 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
- Aug 19, 2025InsiderChair sold ~$4.23M of COR shares in the open market
- Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
- Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 (10x10) blisterpacks, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. 50 Tablet…
- Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
- Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10)…
- Sep 5, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
- Sep 15, 2025FDARecall: Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carto…
- Sep 16, 2025InsiderChair sold ~$9.09M of COR shares in the open market
- Sep 18, 2025InsiderCEO sold ~$1.48M of COR shares in the open market
- Oct 1, 2025InsiderOfficer sold ~$591K of COR shares in the open market
- Oct 9, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC […
- Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 606…
- Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
- Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
- Oct 20, 2025InsiderCEO sold ~$1.67M of COR shares in the open market
- Nov 5, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Nov 18, 2025InsiderCEO sold ~$1.87M of COR shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Cencora
For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.
How this filing works
Explore the data
Common questions
What does this filing report about Cencora (COR) stock?
Viking Global added to its stake in Cencora, per its Q2 2025 13F. Now 2.08M shares, $624M reported value, 1.8% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2025. Filed: Aug 14, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Cencora recently?
For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the COR page.
Does this mean COR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Cencora
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 4Oct 5, 2026
- SEC Form 4Sep 17, 2026
- SEC Form 144Sep 16, 2026
- SEC Form 144Sep 11, 2026
Everything OQRO holds on this company is on its COR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
